指南与共识流行病学与生物统计医学教育与科研方法

现有包容性试验方法学研究指南:整合定性研究与公平、多元、包容的聚焦映射综述

Existing research guidelines for inclusive trials methodology. Working toward the integration of qualitative research, equity, diversity, and inclusion and trials methodology: a focused mapping review.
指南 / 共识 · J Clin Epidemiol · 2026-02-21

该聚焦映射综述识别了15部关于包容性试验方法学的指南,将其映射到12阶段试验生命周期框架,发现多数指南侧重试验早期阶段,对后期阶段关注不足;公平、多元、包容(EDI)维度上对种族/民族、性别、社会经济地位和残疾关注较强,但对性身份、教育或交叉性关注有限。定性研究可弥补这些缺口。

要点

  • 现有包容性试验指南多集中于试验早期设计阶段,后期阶段指导有限。
  • EDI维度中对性身份、教育及交叉性关注不足。
  • 定性研究可用于捕捉参与者视角,支持全试验周期的包容性实践。

核心结论

  • 当前包容性指南集中于试验设计早期,对后期阶段关注有限。
  • 定性研究通过捕捉参与者视角,可帮助弥补全试验周期的包容性缺口。

研究设计与样本

  • 聚焦映射综述与综合(FMRS),纳入涉及人体参与者的3期及以后临床试验的公开指南。
  • 共识别15部指南,映射至基于SPIRIT和CONSORT 2025条目构建的12阶段试验生命周期框架(Q-ASSIST试验阶段模型)。
  • 采用叙事综合,按PRO-EDI框架结构化发现,并与O'Cathain等试验中定性研究框架并置比较。

主要发现

  • 多数指南强调试验早期阶段,后期阶段较少涉及。
  • 映射至PRO-EDI框架显示对种族/民族、性别、社会经济地位和残疾关注较强。
  • 对性身份、教育或交叉性关注有限。
  • 与O'Cathain等框架并置显示定性研究的使用存在类似缺口,尤其在试验后期阶段。

临床怎么用

  • 可参照Q-ASSIST试验阶段模型组织包容性指导,覆盖全试验生命周期。
  • 在试验后期阶段引入定性研究以补充参与者视角和包容性实践。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Equity, diversity, and inclusion (EDI) are increasingly emphasized in clinical research, yet practical guidance for applying inclusion principles across all clinical trial stages remain limited. Qualitative research can help address this gap by exploring participant experiences and identifying barriers to inclusive trial conduct. The aim of this review is to map guidelines and recommendations in relation to inclusive trials methodology and to identify areas across these resources that can be potentially informed by qualitative research. This review presents Phases 1 and 2 of the QuAlitative reSearch Supporting IncluSive Trials (Q-ASSIST) study. METHODS: In Phase 1, we conducted a focused mapping review and synthesis (FMRS) of publicly available guidelines related to Phase 3 and later clinical trials involving human participants. Eligible guidelines included those offering recommendations to enhance inclusive trial design and conduct. Each guideline was mapped to a priori data extraction framework informed by the Standard Protocol Items: Recommendations for Interventional Trials and Consolidated Standards of Reporting Trials 2025 guidelines. We then performed a narrative synthesis to examine the EDI focus of the selected guidelines and structured the findings according to the PRO-EDI Framework. In Phase 2, we juxtaposed the trial stages identified through our FMRS with O'Cathain et al's framework of qualitative research in trials. RESULTS: We identified 15 guidelines through FMRS. Through conceptual mapping to Standard Protocol Items: Recommendations for Interventional Trials and Consolidated Standards of Reporting Trials headings, we developed a 12-stage trial lifecycle framework (the Q-ASSIST trial stages model) to organize inclusion guidance. Most guidelines emphasized early stages of trials, with later stages less frequently addressed. Mapping to the PRO-EDI framework showed strong attention to race/ethnicity, gender, socioeconomic status, and disability, but limited focus on sexual identity, education, or intersectionality. Juxtaposition with O'Cathain et al's framework highlighted similar gaps in how qualitative research has been used, especially in later trial stages. CONCLUSION: Current inclusion guidance is concentrated in the early stages of trial design, with limited attention to later trial stages. Qualitative research offers a valuable way to address these gaps by capturing participant perspectives and supporting inclusive practices across the trial lifecycle. This review provides a foundation for developing practical tools to guide more inclusive trials, with the next phase involving coproduction of guiding principles with interest holders.

来源:J Clin Epidemiol,查看原文。版权归原作者所有。

引用

  1. Thomas T, Jones L, Dawson S, et al. Existing research guidelines for inclusive trials methodology. Working toward the integration of qualitative research, equity, diversity, and inclusion and trials methodology: a focused mapping review. J Clin Epidemiol. 2026. PMID: 41730342. doi:10.1016/j.jclinepi.2026.112202

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。